Newsroom | 5069 results

BIRMINGHAM, Ala.--(BUSINESS WIRE)--TIXiMED, Inc., a clinical-stage pharmaceutical company developing innovative therapies for diabetes based on the breakthrough discovery of the role of TXNIP in disease progression, today announced the expansion of a program-related investment (PRI) made by The Leona M. and Harry B. Helmsley Charitable Trust in furtherance of their charitable purpose. The expanded PRI, in the form of a loan, provides TIXiMED with an additional $2.2 million to support the compan...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S....

DENVER--(BUSINESS WIRE)--Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II clinical trial (RCT), offering an early signal that could reshape how advanced pancreatic cancer is treated. Conducted in partnership with USC Norris Comprehensive Cancer Center, Mayo Clinic, HonorHealth Research Institute, and others, the study was peer-reviewed and published in Cancer, revealing that Virta’s medically supervised, individualized nutri...

LOUISVILLE, Ky.--(BUSINESS WIRE)--A new study published in the current issue of the Journal of Managed Care & Specialty Pharmacy (JMCP)—conducted by a Humana Healthcare Research team and Dr. Joseph S. Ross of the Yale School of Medicine—reveals a notable increase in the use of continuous glucose monitors (CGMs) among Medicare Advantage members with type 2 diabetes from 2021 to 2023. The study also compared the demographic and clinical characteristics of members with type 2 diabetes who used...

BOSTON--(BUSINESS WIRE)--Carna Health, a digital health company revolutionizing kidney care and related cardio-kidney metabolic (CKM) conditions, announced the expansion of its global chronic kidney disease (CKD) screening programs on World Kidney Day. Leveraging AI-enabled early detection and follow-up care, Carna Health is scaling initiatives across multiple regions to identify CKD before it reaches advanced stages and connect patients with timely treatment. “Since launching our first program...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes...

BARCELONA, Spain--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for people with all types of diabetes and share more details about future product features across its global portfolio at the upcoming 19th annual Advanced Technologies and Treatments for Diabetes Conference in Barcelona, March 11-14, 2026. “There is no better global stage than ATTD to showcase how we’re...

BIRMINGHAM, Alabama--(BUSINESS WIRE)--TIXiMED, Inc., une société pharmaceutique au stade clinique qui développe un nouveau traitement oral ciblant la protéine TXNIP (thioredoxin-interacting protein) pour le diabète et les troubles métaboliques, est heureuse de présenter de nouvelles recherches menées par des chercheurs du Comprehensive Diabetes Center de l'University of Alabama at Birmingham (UAB). L'étude démontre que son composé oral, le TIX100, prévient efficacement la reprise pondérale aprè...

BIRMINGHAM, Ala.--(BUSINESS WIRE)--TIXiMED, Inc., a clinical-stage pharmaceutical company developing a novel oral therapy targeting thioredoxin-interacting protein (TXNIP) for diabetes and metabolic disorders, is pleased to highlight new research by investigators at the University of Alabama at Birmingham (UAB) Comprehensive Diabetes Center. The study demonstrates that its oral compound, TIX100, effectively prevents weight rebound following discontinuation of GLP-1 treatment in a mouse model of...

GOTHENBURG, Sweden--(BUSINESS WIRE)--Glooko, Inc., a globally integrated digital healthcare company focused on helping healthcare systems solve the growing challenges of glycemic safety and diabetes management across care settings, today announced that the Glooko platform will integrate with the Roche Accu-Chek SmartGuide continuous glucose monitoring (CGM) solution across select European countries, subject to local availability.* This integration will enable people using the Accu-Chek SmartGui...